Included support
- +Hospital matching
- +Record review
- +Care coordination
- +Travel support
- +Interpretation support

Chest radiotherapy can be considered when local control of primary and mediastinal lesions in the chest is required for small cell lung cancer, such as concurrent or sequential chemoradiotherapy for limited-stage disease, or consolidation irradiation of residual lesions after systemic therapy for ex
24-72h
Response window
Approx. $3,200
Treatment fee
Peking Union Medical College Hospital - Beijing - Grade 3A
Ruijin Hospital - Shanghai - Grade 3A
West China Hospital - Chengdu - Grade 3A
Let us coordinate the treatment journey with you.
This treatment course typically begins with body position fixation and localization imaging, with optional thermoplastic masks for fixation. The doctor delineates the target area and organs at risk on the localization CT (with MRI/PET fusion if necessary), and the physicist optimizes the intensity-modulated/volumetric modulated arc therapy plan and completes quality control. The treatment is administered in fractions, with on-machine imaging to correct the positioning and gradually accumulate the dose. During this period, respiratory, skin, and esophageal reactions are monitored, with the goal of controlling chest lesions while protecting normal tissues. The above is general health information, not medical advice; specific details are subject to specialist evaluation and hospital protocols.
This treatment course typically begins with body position fixation and localization imaging, with optional thermoplastic masks for fixation. The doctor delineates the target area and organs at risk on the localization CT (with MRI/PET fusion if necessary), and the physicist optimizes the intensity-modulated/volumetric modulated arc therapy plan and completes quality control. The treatment is administered in fractions, with on-machine imaging to correct the positioning and gradually accumulate the dose. During this period, respiratory, skin, and esophageal reactions are monitored, with the goal of controlling chest lesions while protecting normal tissues. The above is general health information, not medical advice; specific details are subject to specialist evaluation and hospital protocols.

Including preoperative evaluation and planning, the entire treatment process, and initial follow-up, it is recommended to stay for approximately 5–7 weeks in total, subject to scheduling and individual recovery.

Tell us about your Small Cell Lung Cancer case and we will help match you with the right hospital, specialist, and travel pathway.